Verséa Discovery

Verséa Discovery is a specialized division of Verséa Health that focuses on the development and commercialization of transformative diagnostic solutions and biomarker discovery tools. Based in Tampa, Florida, the company provides high-sensitivity point-of-care (POC) testing platforms, most notably for quantitative C-reactive protein (hs-CRP) to assess systemic inflammation and cardiovascular risk. Beyond diagnostics, Verséa Discovery offers research services and tools designed to accelerate clinical research and improve patient management through precision medicine. Their portfolio serves clinical laboratories, research institutions, and healthcare providers seeking rapid, lab-quality results in decentralized settings. The company's platform is built to support the validation and implementation of novel biomarkers into clinical practice.